A few healthcare upgrades and downgrades for Tuesday


BioCryst (BCRXupgraded to Neutral from Underperform at BofA.

Exelixis (EXEL) upgraded to Buy from Hold at Maxim.

Sarepta Therapeutics (SRPT) cut to Underweight from Overweight at Piper.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs